Edinburgh, Scotland (3 December 2024) - Blackford, the pioneering Enterprise AI platform and solutions provider, and Aival, an AI Assurance company providing software for comparison, evaluation and monitoring of AI solutions, today announced a commercial partnership to bring the Aival Analysis Lab to healthcare professionals via the Blackford Platform.
Blackford’s proven platform offers healthcare providers access to a broad portfolio of over 140 AI solutions, designed to improve clinical accuracy, streamline workflows, and elevate patient outcomes. Integrating the Aival Analysis Lab into the Blackford Platform allows healthcare providers to compare and evaluate AI products, curate ground-truth with local imaging data, and monitor deployed AI products.
“We are pleased to partner with Aival and integrate their Analysis Lab into the Blackford AI Platform portfolio,” says Ben Panter, Founder and CEO of Blackford. “This collaboration allows us to enhance our support to healthcare providers who want to evaluate and monitor AI solutions, helping drive the adoption of AI, improving operational efficiencies across healthcare systems, and further advancing our mission to improve patient health around the world.”
The Aival Analysis Lab is a suite of software that enables clinical users to independently evaluate, compare and monitor the performance of AI products on-the-market. This facilitates standardized assessment processes and reporting across different vendors and applications, targeted to the healthcare provider’s local setting. Aival provides validation of AI products before and after deployment, allowing a user to objectively choose between similar products, then ensure a deployed product continues to work well and safely over time.
“We are delighted to bring the Aival Analysis Lab suite of software for AI assurance to the Blackford platform. We have long been impressed with Blackford’s focus on customer needs and commitment to trustworthy AI, as well as their expertise in implementing technological solutions. Through this partnership, we aim to offer customers greater transparency into the safety and effectiveness of AI products, and confidence in their choice and use over time. Together, we are looking forward to advancing our shared goal of unlocking the transformative value of AI that best serves the needs of healthcare providers and patients. Kanwal Bhatia, Founder & CEO of Aival.”